Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4K Sell
29
-9
-24% -$4.15K ﹤0.01% 1132
2026
Q1
$18.2K Sell
38
-16
-30% -$8.19K ﹤0.01% 1018
2025
Q4
$30.3K Buy
54
+5
+10% +$2.84K ﹤0.01% 885
2025
Q3
$25.2K Buy
+49
New +$21.4K ﹤0.01% 800

Other funds holding MEDP

Quent Capital's MEDP Position: Q2 2026 in Review

Quent Capital reduced its Medpace (MEDP) stake by 24% in Q2 2026, selling an estimated $4.15K and leaving 29 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1132.

Quent Capital first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $30.3K in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Quent Capital held 29 shares of Medpace worth $15.4K as of Q2 2026.
  • Quent Capital sold 9 Medpace shares in Q2 2026, an estimated $4.15K.
  • Medpace made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1132 holding.
  • Quent Capital first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • Quent Capital's Medpace position peaked at $30.3K in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.